Treat-to-target strategy in patients with rheumatoid arthritis: Audit of adherence from real world clinical data José-Luis Andréu; María Auxiliadora Martín; Héctor Corominas; José Javier Pérez-Venegas; José Andrés Román-Ivorra; Fernando Sánchez-Alonso; Ángel Gil de Miguel;

Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis José María Álvaro-Gracia Álvaro; Petra Díaz del Campo Fontecha; José Luis Andréu Sánchez; Alejandro Balsa Criado; Rafael Cáliz Cáliz; Isabel Castrejón Fernández; Hèctor Corominas; José A. Gómez Puerta; Sara Manrique Arija; Natalia Mena Vázquez; Ana Ortiz García; Chamaida Plasencia Rodríguez; Lucía Silva Fernández; Jesús Tornero Molina;

Elderly-onset rheumatoid arthritis receives less aggressive therapies than young-onset rheumatoid arthritis in an Argentinian cohort Nicolás Pérez; María de Los Ángeles Gargiulo; Marina Khoury; Lorena Suárez; María de los Ángeles Correa; Mariana Pera; Natali Saravia; Graciela Gómez;